Clinical Pearls from the NCCN 2013 Oncology Pharmacy Best Practices Webinar Series
Pharmacists are important to the clinical decision-making process, both at the individual patient level and the drug use policy level. At the individual patient level, the oncology multidisciplinary team typically includes a clinical pharmacist who specializes in oncology. Furthermore, pharmacists dispensing chemotherapy require the clinical knowledge and expertise to effectively assess the appropriateness of therapy (i.e., for indication, dosing, etc.) and monitor the patient for adverse effects. Pharmacists also must be knowledgeable about specific drugs to be able to effectively counsel a patient regarding medications. At the policy level, pharmacists are actively involved in the formation of drug use policy though their participation on Pharmacy & Therapeutics committees for hospitals and managed care organizations. Often, the pharmacist on the committee performs the literature review and writes the policy for the committee to approve.
These activities are designed to meet the educational needs of pharmacists.
These activities are approved for pharmacy (ACPE) credits. Complete accreditation information is provided before each individual educational activity.
There is no fee for these activities.
This activity is supported by an educational donation from Amgen.